To understand the role of EGFR in regulating the aggressiveness of IBC, we assessed the impact of the EGFR pathway on the IBC cell population expressing CSC markers, defined as the CD44+/CD24−/low or ALDH+ fraction, and on mammosphere formation. This evidence concerns the gene EGFR and inflammatory breast carcinoma.